about
Hypoxia-inducible factors as molecular targets for liver diseasesAdenosine receptor signaling: a key to opening the blood-brain doorBlood cells: an historical account of the roles of purinergic signallingCrosstalk between purinergic receptors and lipid mediators in leishmaniasisTrichomoniasis immunity and the involvement of the purinergic signalingP2X7 receptors induce degranulation in human mast cellsThe role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite controlNonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6.P2X7 on Mouse T Cells: One Channel, Many FunctionsMulti-Inhibitory Effects of A2A Adenosine Receptor Signaling on Neutrophil Adhesion Under FlowLoss of CD73-mediated actin polymerization promotes endometrial tumor progression.Extracellular ATP mediates inflammatory responses in colitis via P2 × 7 receptor signalingExtracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.Purinergic Signaling and the Immune Response in Sepsis: A ReviewDivide, Conquer, and Sense: CD8+CD28- T Cells in Perspective.Contribution of the Purinergic Receptor P2X7 to Development of Lung Immunopathology during Influenza Virus Infection.The role of connexin and pannexin containing channels in the innate and acquired immune response.NUDT2 Disruption Elevates Diadenosine Tetraphosphate (Ap4A) and Down-Regulates Immune Response and Cancer Promotion Genes.Unlocking the Potential of Purinergic Signaling in TransplantationRegulation of the T Cell Response by CD39.Inseparable tandem: evolution chooses ATP and Ca2+ to control life, death and cellular signalling.Short- and long-term (trophic) purinergic signalling.Imaging Adenosine Triphosphate (ATP)Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg).Purinergic signalling links mechanical breath profile and alveolar mechanics with the pro-inflammatory innate immune response causing ventilation-induced lung injury.Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice.Purinergic Signaling: A Common Path in the Macrophage Response against Mycobacterium tuberculosis and Toxoplasma gondii.Leishmania amazonensis-Induced cAMP Triggered by Adenosine A2B Receptor Is Important to Inhibit Dendritic Cell Activation and Evade Immune Response in Infected Mice.Substrate-Dependence of Competitive Nucleotide Pyrophosphatase/Phosphodiesterase1 (NPP1) Inhibitors.Purinergic signaling in infection and autoimmune disease.ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells.T cell inhibitory mechanisms in a model of aggressive Non-Hodgkin's Lymphoma.Purinergic Signaling in Mast Cell Degranulation and Asthma.ATP Evokes Ca2+ Responses and CXCL5 Secretion via P2X4 Receptor Activation in Human Monocyte-Derived Macrophages.The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.Structure, Pharmacology and Roles in Physiology of the P2Y12 Receptor.Purinergic signalling displays an anti-inflammatory profile in the spleen of fish experimentally infected with Aeromonas caviae: Modulation of the immune response.Adenine Nucleotides Attenuate Murine T Cell Activation Induced by Concanavalin A or T Cell Receptor Stimulation.P2Y12 Receptors in Tumorigenesis and Metastasis.Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity.
P2860
Q26752304-0DE20692-53AA-43D6-B147-7B9B2E0FBE1CQ26795435-6A85A221-7D38-4743-B542-1D76A5222117Q26799623-70ABCDA7-1C1F-4C30-9042-7FB71BA0C0B5Q28072094-14712310-14AE-44A1-94DD-EC6FA6C0C362Q28073292-19C1DD33-3F50-4DE0-A909-9B687D3A4425Q28273611-CC5141AC-B101-4DCC-9B07-61F1934EE765Q33689420-A16F9145-7113-4DB6-B953-AFDA0FF5CFDAQ35595880-FFEB3868-4EB6-4615-89EA-6C38645C40ADQ35621886-39C6F374-A72D-4715-B6E1-655B0B291BC7Q36119376-B90D91F8-A6B6-4084-B16F-9558F0BAC9B8Q36430733-D8A24717-2DD3-401D-B392-6332F170A1DBQ36438334-46697BEC-76D0-42E7-A62B-B9FEA2B7F2E2Q36568428-0DE544B3-5FCF-40C9-8888-2179818A2779Q36923670-0DBF0A65-E6F1-408A-9740-CE79C2C5EE10Q37550716-F6EEA4CB-E8F9-43BD-92AA-F3DD7E20E9D7Q37727159-1E54D9F8-564F-460A-ACE6-36162DA1C4E4Q38755727-EE1C3134-ACCC-4293-B622-98D6CFC21A58Q38773238-92101CAD-CEF3-4AC6-8AB9-B5F1C822D4EDQ38785475-E7AB2D35-4834-4A2E-8BAF-F1B6E46A6844Q38847228-2BFA60F9-AFF3-48E1-945D-DD1DE8FE371DQ38885850-82C66EE7-C295-4628-9DF2-9C205FD65AFDQ38885851-FF580F33-0DDD-487E-8134-9AE07D455680Q38957322-8F1D08F7-C1D0-4A39-B953-F3703E88870DQ39281335-47E8ACD8-28AB-4F15-B034-31D0FBE75107Q39331944-44221BE8-013D-4D14-AD5A-7C5D50CD9618Q39777451-E250170E-406D-4E5E-8901-54BBF08E6F13Q40086218-4B491484-8D79-4814-8D58-241F41D3B5E4Q40101180-E70489D2-15B8-4ED8-8EF0-929BB2FFC211Q42321503-491DB456-35C8-4AC5-BFFF-64D416CC8E5BQ43406248-FC998C38-BE19-4B1B-ADAB-1AB843364B7BQ47194065-28A88D82-61AD-46E1-AB2F-8B03E68A7E5EQ47217197-DC487CC1-A12E-4EF7-B664-EFF8E9D68450Q47222005-E93B441A-16EA-4297-B824-8522C11F2984Q47286564-22B889E7-B8FD-4795-AB8D-EBA6BB7B638DQ47571865-C7ABC2E4-7CBE-4E49-BBBB-B723FB35BAF3Q47786748-E814D2E8-E67A-48D9-B646-4442E0CB9E64Q48371706-B2237B74-BA3B-4EAA-AA8C-03041E288AB1Q49256041-73EC3A68-D28B-46F5-88B5-4CF78E21B3F6Q49884998-71CD47AB-A579-4699-8A84-1212401EB3BFQ50093296-55C7BB6D-FC70-410F-A49F-020CB03C18A2
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Purinergic signalling and immune cells.
@en
type
label
Purinergic signalling and immune cells.
@en
prefLabel
Purinergic signalling and immune cells.
@en
P2860
P921
P1476
Purinergic signalling and immune cells.
@en
P2093
Geoffrey Burnstock
Jean-Marie Boeynaems
P2860
P2888
P304
P356
10.1007/S11302-014-9427-2
P577
2014-10-29T00:00:00Z
2014-12-01T00:00:00Z
P5875
P6179
1049945381